Vera Therapeutics, Inc. (VERA) — Stock Score Summary

Vera Therapeutics, Inc. (VERA) has a MoatMap StockRank of 34/100 based on Quality (34/100), Value (35/100), and Momentum (53/100) factor scores. The current signal is HOLD.

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing innovative therapies for patients with serious immunological and inflammatory diseases. The company's competitive moat is derived from its pipeline of differentiated drug candidates, particularly its lead asset for IgA nephropathy, addressing conditions with high unmet medical needs. Vera Therapeutics aims to deliver transformative treatments for autoimmune diseases.

Key Financial Metrics

Price$35.86
Market Cap$2.6B
P/E (Forward)-9.58
Price/Book4.93
Return on Equity-71.3%
Return on Invested Capital-42.9%
Debt/Equity15.39
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-179M

Vera Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Vera Therapeutics, Inc.’s (VERA) StockRank?
MoatMap’s StockRank for Vera Therapeutics, Inc. (VERA) is 34/100, with a Hold signal. It is a composite of Quality (34), Value (35), and Momentum (53) factor ranks across MoatMap’s 19,000+ stock universe.
Does Vera Therapeutics, Inc. have an economic moat?
Vera Therapeutics, Inc. (VERA) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vera Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Vera Therapeutics, Inc. (VERA) is Hold, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vera Therapeutics, Inc. in?
Vera Therapeutics, Inc. (VERA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVERA deep dive reportAI ChampionsHow we score stocksSense-check another stock